CNBX Pharmaceuticals Inc. (CNBX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2013: -$58.1K2014: -$216.1K2015: -$536.5K2016: -$280.7K2017: -$1.85M2018: -$3.81M2019: -$3.30M2020: -$3.04M2021: -$2.60M2022: -$2.95M2023: -$931.4K2024: -$583.1K2025: -$271.7K-$271.7K
2013Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$271.7K+53.4%
2024-$583.1K+37.4%
2023-$931.4K+68.5%
2022-$2.95M-13.6%
2021-$2.60M+14.6%
2020-$3.04M+7.9%
2019-$3.30M+13.3%
2018-$3.81M-105.4%
2017-$1.85M-560.5%
2016-$280.7K+47.7%
2015-$536.5K-148.2%
2014-$216.1K-271.9%
2013-$58.1K